Efficacy of High-Dose Intravenous Methylprednisolone in Ethambutol-Induced Optic Neuropathy: Insights from a Double-Blind RCT
A randomized, placebo-controlled trial shows short-term high-dose intravenous methylprednisolone improves visual outcomes in ethambutol-induced optic neuropathy, providing a promising therapeutic strategy pending validation in larger studies.
